Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

English
中文
Deutsch
Español
Français
日本語
Português

News

Texas Issues Proposed Rule on SB25 Ingredient Warning Labeling Law

03 October 2025

Insights and Analysis

FDA DSCSA Public Meeting Highlights Interdependence of Trading Partners

03 October 2025

Insights and Analysis

FDA PreCheck meeting weighs how more clarity may help de-risk US manufacturing investments

03 October 2025

News

The DOJ’s Health Care Fraud Strike Force comes to Massachusetts: What this could mean for companies

01 October 2025

News

Impact of Government Shutdown on FDA and FSIS Activities

01 October 2025

News

FDA finalizes computer software assurance guidance for production and quality system software

29 September 2025

News

FDA announces new resources related to foodborne outbreaks and investigations

26 September 2025

News

OMB Releases Spring 2025 Unified Agenda of Regulatory Actions

24 September 2025

Insights and Analysis

FDA enforcement against SeniorLife, Whoop signal new line in the sand for AI health apps

19 September 2025

News

FDA medical device inspections in 2025: What we're seeing, what we expected, and why you need the right expertise now

18 September 2025

News

Mexico unveils 2025-2030 Environmental Sector Program

15 September 2025

News

FDA ramps up drug ad enforcement, targets social media

11 September 2025

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Our thinking

News

Insights and Analysis

Insights and Analysis

News

News

News

News

News

Insights and Analysis

News

News

News

No results found